Table of Content

1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 MARKET SCOPE 17
1.3.1 MARKETS COVERED 17
1.3.2 YEARS CONSIDERED FOR THE STUDY 18
1.4 CURRENCY 18
1.5 LIMITATIONS 18
1.6 STAKEHOLDERS 19
1.7 SUMMARY OF CHANGES 19

2 RESEARCH METHODOLOGY 21
2.1 RESEARCH DATA 21
2.1.1 SECONDARY DATA 22
2.1.1.1 Key data from secondary sources 22
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 24
2.1.2.2 Breakdown of primary sources 24
2.2 MARKET SIZE ESTIMATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 30
2.4 MARKET SHARE ESTIMATION 30
2.5 ASSUMPTIONS FOR THE STUDY 31

3 EXECUTIVE SUMMARY 32

4 PREMIUM INSIGHTS 35
4.1 DIABETES CARE DEVICES MARKET OVERVIEW 35
4.2 DIABETES CARE DEVICES (BRIC) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 36
4.3 DIABETES CARE DEVICES (BRIC) MARKET: COUNTRY MIX (2020–2025) 37

5 INDUSTRY INSIGHTS 38
5.1 INDUSTRY TRENDS 38
5.1.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS 38
5.1.2 SMART GLUCOSE METERS ENABLE INTEGRATED DIABETES MANAGEMENT SOLUTIONS 39
5.1.3 SMART INSULIN PEN SYNCHRONIZATION WITH GLUCOSE MONITORING SYSTEMS PROMOTES DIABETES DATA SHARING 41
5.1.4 INNOVATIVE INSULIN DELIVERY SYSTEMS 42
?
5.2 REGULATORY ANALYSIS 43
5.2.1 CHINA 43
5.2.2 INDIA 43
5.2.3 BRAZIL 44
5.2.4 RUSSIA 45
5.3 COVID-19 IMPACT ON THE DIABETES CARE DEVICES (BRIC) MARKET 45

6 DIABETES CARE DEVICES MARKET, BY TYPE 46
6.1 INTRODUCTION 47
6.2 BLOOD GLUCOSE MONITORING SYSTEMS 48
6.2.1 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS 49
6.2.1.1 Technological innovations to drive the growth of self-monitoring blood glucose monitoring systems 49
6.2.2 CONTINUOUS GLUCOSE MONITORING SYSTEMS 53
6.2.2.1 Increasing collaborations, partnerships, and agreements between companies to develop integrated CGM systems to drive the growth of this market 53
6.2.3 TEST STRIPS/TEST PAPERS 56
6.2.3.1 Shift toward non-invasive methods for blood glucose monitoring to restrain the growth of this market during the forecast period 56
6.2.4 LANCETS/LANCING DEVICES 58
6.2.4.1 Rising focus to reduce the chances of infection and accidental pricking to increase the popularity of safety lancets during the forecast period 58
6.3 INSULIN DELIVERY DEVICES 59
6.3.1 INSULIN PUMPS 60
6.3.1.1 Insulin pumps integrated with continuous glucose monitoring systems offer the benefits of data integration and diabetes management 60
6.3.2 INSULIN PENS 62
6.3.2.1 The convenience of use of insulin pens and increasing affordability could drive the growth of this segment during the forecast period 62
6.3.3 INSULIN SYRINGES AND NEEDLES 64
6.3.3.1 Safety concerns and increasing awareness of affordable alternatives in the market could restrain the growth of this segment during the forecast period 64
6.4 DIABETES MANAGEMENT MOBILE APPLICATIONS 67
6.4.1 GROWING ADOPTION OF BLOOD GLUCOSE TRACKING APPS AND INCREASING AWARENESS OF DIABETES AMONG PATIENTS TO
DRIVE MARKET GROWTH 67

7 DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS 69
7.1 INTRODUCTION 70
7.2 SELF/HOME HEALTHCARE 70
7.2.1 INCREASING AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES HAS FUELED THE PREFERENCE FOR SELF/HOME HEALTHCARE 70
7.3 HOSPITALS & DIABETES SPECIALTY CLINICS 71
7.3.1 RISING DEMAND FOR POC TESTING IN HOSPITALS BOOSTS THE MARKET GROWTH 71

8 DIABETES CARE DEVICES MARKET IN BRIC COUNTRIES 73
8.1 INTRODUCTION 74
8.2 CHINA: DIABETES CARE DEVICES MARKET 75
8.2.1 INTRODUCTION 76
8.2.2 MARKET DRIVERS 76
8.2.2.1 Sharp increase in diabetes in the past decade 76
8.2.2.2 Favorable national health strategies 77
8.2.2.3 Government-LED endorsement of the medical device industry 77
8.2.3 MARKET RESTRAINTS 77
8.2.3.1 Traditional Chinese medicine as an alternative 77
8.2.3.2 High cost of advanced diabetes management devices 78
8.2.4 MARKET OPPORTUNITIES 78
8.2.4.1 Significant advancements and leveraging of artificial intelligence and big data 78
8.2.5 MARKET CHALLENGES 79
8.2.5.1 Lack of adherence of patients to recommended diabetes treatment guidelines 79
8.3 INDIA: DIABETES CARE DEVICES MARKET 82
8.3.1 INTRODUCTION 83
8.3.2 MARKET DRIVERS 83
8.3.2.1 High prevalence of diabetes 83
8.3.2.2 Government’s “Make in India” campaign to encourage local manufacturing of medical devices 84
8.3.2.3 Diabetes awareness campaigns and screening camps 84
8.3.3 MARKET RESTRAINTS 85
8.3.3.1 Lack of accessibility to healthcare 85
8.3.3.2 Inadequate health insurance coverage 85
8.3.4 MARKET OPPORTUNITIES 85
8.3.4.1 Rising adoption of Mhealth 85
8.3.5 MARKET CHALLENGES 86
8.3.5.1 Shortage of healthcare professionals in diabetes management 86
8.4 BRAZIL: DIABETES CARE DEVICES MARKET 88
8.4.1 INTRODUCTION 89
8.4.2 MARKET DRIVERS 89
8.4.2.1 High prevalence of diabetes 89
8.4.2.2 Favorable government policies 90
8.4.3 MARKET RESTRAINTS 90
8.4.3.1 Lack of awareness of diabetes care 90
8.4.3.2 High prices of advanced diabetes care devices 90
8.4.4 MARKET OPPORTUNITIES 91
8.4.4.1 Increasing penetration of smartphones and rising focus on digital health to drive the growth of diabetes management platforms and diabetes management mobile applications 91
8.4.5 MARKET CHALLENGES 91
8.4.5.1 Strict regulatory guidelines and regulatory process for medical devices 91
8.5 RUSSIA: DIABETES CARE DEVICES MARKET 94
8.5.1 INTRODUCTION 95
8.5.2 MARKET DRIVERS 95
8.5.2.1 Rising elderly population 95
8.5.2.2 Increasing rate of obesity 96
8.5.3 MARKET RESTRAINTS 96
8.5.3.1 Large number of undiagnosed diabetics 96
8.5.4 MARKET OPPORTUNITIES 96
8.5.4.1 Government spending on healthcare 96
8.5.4.2 Rising investment of pharma market players to establish local manufacturing plants 97
8.5.5 MARKET CHALLENGES 97
8.5.5.1 Low adoption of glucose monitoring systems 97

9 COMPETITIVE LANDSCAPE 100
9.1 OVERVIEW 100
9.2 PRODUCT BENCHMARKING 103
9.3 GEOGRAPHIC REACH OF THE TOP MARKET PLAYERS (2019) 104
9.4 R&D EXPENDITURE: KEY PLAYERS IN THE DIABETES CARE DEVICES (BRIC) MARKET 105
9.5 MARKET SHARE ANALYSIS 105
9.5.1 BRAZIL: DIABETES CARE DEVICES MARKET SHARE ANALYSIS 105
9.5.2 RUSSIA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS 107
9.5.3 INDIA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS 108
9.5.4 CHINA: DIABETES CARE DEVICES MARKET SHARE ANALYSIS 109
9.6 COMPETITIVE SITUATION AND TRENDS 110
9.6.1 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS 110
9.6.2 PRODUCT APPROVALS, LAUNCHES, AND UPGRADES 113

10 COMPANY PROFILES 115
(Business overview, Products offered, Recent developments, SWOT analysis, MNM view)*
10.1 F. HOFFMAN-LA ROCHE LTD. 115
10.2 ABBOTT 119
10.3 ASCENSIA DIABETES CARE HOLDINGS AG 123
10.4 DEXCOM, INC. 127
10.5 MEDTRONIC PLC 131
10.6 B. BRAUN MELSUNGEN AG 135
10.7 BECTON, DICKINSON AND COMPANY 137
10.8 ACON LABORATORIES, INC. 139
10.9 ARKRAY, INC. 140
10.10 SANOFI 142
10.11 NOVO NORDISK A/S 144
10.12 TERUMO CORPORATION 146
10.13 YPSOMED 148
10.14 SINOCARE, INC. 150
10.15 AGAMATRIX HOLDINGS LLC 152
10.16 LIFESCAN 154
10.17 SD BIOSENSOR, INC. 156
10.18 MICROGENE DIAGNOSTIC SYSTEMS PVT. LTD. 157
10.19 DR. MOREPEN 158
10.20 BIONIME CORPORATION 159
10.21 ROSSMAX INTERNATIONAL LTD. 160
*Business overview, Products offered, Recent developments, SWOT analysis, MNM view might not be captured in case of unlisted companies.
11 APPENDIX 161
11.1 INSIGHTS OF INDUSTRY EXPERTS 161
11.2 DISCUSSION GUIDE 162
11.3 KNOWLEDGE STORE 165
11.4 AVAILABLE CUSTOMIZATIONS 167
11.5 RELATED REPORTS 167
11.6 AUTHOR DETAILS 168



List of Figures



FIGURE 1 RESEARCH DESIGN 21
FIGURE 2 PRIMARY SOURCES 23
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND COUNTRY 24
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 25
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 26
FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 27
FIGURE 7 DATA TRIANGULATION METHODOLOGY 30
FIGURE 8 DIABETES CARE DEVICES (BRIC) MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION) 32
FIGURE 9 SELF/HOME HEALTHCARE WILL DOMINATE THE MARKET DURING THE FORECAST PERIOD 33
FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE DIABETES CARE DEVICES (BRIC) MARKET 34
FIGURE 11 INCREASING PREVALENCE OF DIABETES AND THE GROWING DEMAND FOR
NON-INVASIVE GLUCOSE MONITORING AND DIGITAL DIABETES SOLUTIONS DRIVE THE GROWTH OF THE MARKET 35
FIGURE 12 INDIA TO REGISTER THE FASTEST GROWTH IN THE DIABETES CARE DEVICES (BRIC) MARKET DURING THE FORECAST PERIOD 36
FIGURE 13 BRAZIL TO WITNESS THE SECOND-FASTEST GROWTH DURING THE FORECAST PERIOD (2020–2025) 37
FIGURE 14 GEOGRAPHIC SNAPSHOT: DIABETES CARE DEVICES MARKET IN BRIC COUNTRIES 74
FIGURE 15 NUMBER OF ADULT DIABETICS IN CHINA (MILLION) 76
FIGURE 16 CHINA: DIABETES CARE DEVICES MARKET SNAPSHOT 80
FIGURE 17 TOP 5 COUNTRIES WITH THE HIGHEST NUMBER OF CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES (0-14 YEARS) IN 2019 84
FIGURE 18 INDIA: DIABETES CARE DEVICES MARKET SNAPSHOT 86
FIGURE 19 YEAR-ON-YEAR DIABETES PREVALENCE (BRAZIL) 89
FIGURE 20 BRAZIL: DIABETES CARE DEVICE MARKET SNAPSHOT 92
FIGURE 21 POPULATION AGED ABOVE 65 YEARS AS A PERCENTAGE OF TOTAL POPULATION (RUSSIA) 95
FIGURE 22 RUSSIA: DIABETES CARE DEVICES MARKET SNAPSHOT 98
FIGURE 23 KEY DEVELOPMENTS OF MAJOR PLAYERS BETWEEN JANUARY 2018
AND MAY 2020 101
FIGURE 24 PRODUCT PORTFOLIO ANALYSIS: DIABETES CARE DEVICES MARKET 103
FIGURE 25 DOMESTIC AND FOREIGN PLAYERS IN THE BRAZILIAN DIABETES CARE DEVICES MARKET 106
FIGURE 26 DOMESTIC AND FOREIGN PLAYERS IN THE RUSSIAN DIABETES CARE DEVICES MARKET 107
FIGURE 27 DOMESTIC AND FOREIGN PLAYERS IN THE INDIAN DIABETES CARE DEVICES MARKET 108
FIGURE 28 INDIA: DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2019 108
FIGURE 29 DOMESTIC & FOREIGN PLAYERS IN THE CHINESE DIABETES CARE DEVICES MARKET 109
FIGURE 30 CHINA: DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2019 109
?
FIGURE 31 PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS WERE THE KEY GROWTH STRATEGIES ADOPTED BY MAJOR PLAYERS BETWEEN 2018 AND 2020 110
FIGURE 32 F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT (2019) 115
FIGURE 33 ABBOTT: COMPANY SNAPSHOT (2019) 119
FIGURE 34 DEXCOM, INC.: COMPANY SNAPSHOT (2019) 127
FIGURE 35 MEDTRONIC PLC: COMPANY SNAPSHOT (2019) 131
FIGURE 36 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019) 135
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 137
FIGURE 38 SANOFI: COMPANY SNAPSHOT (2019) 142
FIGURE 39 NOVO NORDISK A/S: COMPANY SNAPSHOT (2019) 144
FIGURE 40 TERUMO CORPORATION: COMPANY SNAPSHOT (2019) 146
FIGURE 41 YPSOMED: COMPANY SNAPSHOT (2019) 148
FIGURE 42 SINOCARE, INC.: COMPANY SNAPSHOT (2019) 150

 

List of Tables



TABLE 1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE DIABETES CARE
DEVICES MARKET 17
TABLE 2 EXCHANGE RATES UTILIZED FOR USD CONVERSION 18
TABLE 3 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO 39
TABLE 4 MAJOR SMART GLUCOSE METERS AVAILABLE GLOBALLY 40
TABLE 5 MAJOR SMART INSULIN PENS AVAILABLE GLOBALLY 42
TABLE 6 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING MEDICAL DEVICES IN BRIC COUNTRIES 43
TABLE 7 CHINA: MEDICAL DEVICE CLASSIFICATION 43
TABLE 8 INDIA: MEDICAL DEVICE CLASSIFICATION 44
TABLE 9 BRAZIL: MEDICAL DEVICE CLASSIFICATION 44
TABLE 10 RUSSIA: MEDICAL DEVICE CLASSIFICATION 45
TABLE 11 AVERAGE SELLING PRICE ANALYSIS OF DIABETES CARE DEVICES (BRIC MARKET) 47
TABLE 12 DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 47
TABLE 13 DIABETES CARE DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 48
TABLE 14 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE 2018–2025 (USD MILLION) 48
TABLE 15 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 49
TABLE 16 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY COUNTRY, 2018–2025 (USD MILLION) 50
TABLE 17 SELF-MONITORING BLOOD GLUCOSE MONITORING SYSTEMS MARKET BY COUNTRY, 2020–2025 (THOUSAND UNITS) 50
TABLE 18 MAJOR SELF-MONITORING BLOOD GLUCOSE METERS AVAILABLE IN BRIC COUNTRIES 51
TABLE 19 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 54
TABLE 20 CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY 2020–2025 (THOUSAND UNITS) 55
TABLE 21 MAJOR CONTINUOUS GLUCOSE MONITORING SYSTEMS AVAILABLE IN BRIC COUNTRIES 55
TABLE 22 TEST STRIPS/TEST PAPERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 56
TABLE 23 TEST STRIPS/TEST PAPERS (100 STRIPS) MARKET, BY COUNTRY 2020–2025 (THOUSAND UNITS) 57
TABLE 24 MAJOR TEST STRIPS/TEST PAPERS AVAILABLE IN BRIC COUNTRIES 57
TABLE 25 LANCETS/LANCING DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 58
TABLE 26 LANCETS (PER 100) & LANCING DEVICES (PER UNIT) MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS) 58
TABLE 27 MAJOR LANCETS/LANCING DEVICES AVAILABLE IN BRIC COUNTRIES 59
TABLE 28 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 59
TABLE 29 INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 60
TABLE 30 INSULIN PUMPS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 61
TABLE 31 INSULIN PUMPS MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS) 61
TABLE 32 MAJOR INSULIN PUMPS AVAILABLE IN BRIC COUNTRIES 61
TABLE 33 INSULIN PENS MARKET, BY COUNTRY, 2018–2025 (USD MILLION) 63
TABLE 34 INSULIN PENS MARKET, BY COUNTRY, 2020–2025 (THOUSAND UNITS) 63
TABLE 35 MAJOR INSULIN PENS AVAILABLE IN BRIC COUNTRIES 64
TABLE 36 INSULIN SYRINGES AND NEEDLES MARKET, BY COUNTRY 2018–2025 (USD MILLION) 65
TABLE 37 INSULIN SYRINGES AND NEEDLES (PER 100) MARKET, BY COUNTRY 2020–2025 (THOUSAND UNITS) 65
TABLE 38 INSULIN SYRINGES AND NEEDLES AVAILABLE IN BRIC COUNTRIES 66
TABLE 39 DIABETES MANAGEMENT MOBILE APPLICATIONS MARKET, BY COUNTRY 2018–2025 (USD MILLION) 67
TABLE 40 MAJOR DIABETES MANAGEMENT APPLICATIONS AVAILABLE IN BRIC COUNTRIES 68
TABLE 41 DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS 2018–2025 (USD MILLION) 70
TABLE 42 DIABETES CARE DEVICES MARKET FOR SELF/HOME HEALTHCARE, BY COUNTRY, 2018–2025 (USD MILLION) 71
TABLE 43 DIABETES CARE DEVICES MARKET FOR HOSPITAL & DIABETES SPECIALTY CLINICS, BY COUNTRY, 2018–2025 (USD MILLION) 72
TABLE 44 CHINA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 80
TABLE 45 CHINA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE 2018–2025 (USD MILLION) 81
TABLE 46 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 81
TABLE 47 CHINA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS 2018–2025 (USD MILLION) 81
TABLE 48 INDIA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 87
TABLE 49 INDIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE 2018–2025 (USD MILLION) 87
TABLE 50 INDIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 87
TABLE 51 INDIA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS 2018–2025 (USD MILLION) 88
TABLE 52 BRAZIL: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 92
TABLE 53 BRAZIL: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE 2018–2025 (USD MILLION) 93
TABLE 54 BRAZIL: INSULIN DELIVERY DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 93
TABLE 55 BRAZIL: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS 2018–2025 (USD MILLION) 93
TABLE 56 RUSSIA: DIABETES CARE DEVICES MARKET, BY TYPE, 2018–2025 (USD MILLION) 98
TABLE 57 RUSSIA: BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY TYPE 2018–2025 (USD MILLION) 99
TABLE 58 RUSSIA: INSULIN DELIVERY DEVICES MARKET, BY TYPE 2018–2025 (USD MILLION) 99
TABLE 59 RUSSIA: DIABETES CARE DEVICES MARKET, BY PATIENT CARE SETTINGS 2018–2025 (USD MILLION) 99
TABLE 60 MARKET EVALUATION MATRIX (2018–2020) 102
TABLE 61 BRAZIL: DIABETES CARE DEVICES MARKET RANKING, BY KEY PLAYER, 2019 106
TABLE 62 RUSSIA: DIABETES CARE DEVICES MARKET RANKING, BY KEY PLAYER, 2019 107
TABLE 63 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2019-2020) 111
TABLE 64 PRODUCT APPROVALS, LAUNCHES, AND UPGRADES (2019) 113